Shareholders Sue ImClone, Lilly Over Pending Merger
Soon-to-be-merged biotechnology company ImClone Systems Inc. and Eli Lilly and Co. are facing a shareholder class action to bar the companies' pending marriage, which the shareholders have dubbed "a coercive tender...To view the full article, register now.
Already a subscriber? Click here to view full article